NTRA Natera, Inc.
Healthcare$200.91-1.12%ClosedMarket Cap: $28.77B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
16.21
P/S
11.64
EV/EBITDA
-102.87
DCF Value
$-328.63
FCF Yield
0.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
65.2%
Operating Margin
-13.0%
Net Margin
-9.0%
ROE
-15.1%
ROA
-8.7%
ROIC
-11.9%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $696.6M | 64.8% | $-93.5M | $-85.1M | $— | — |
| Q4 null | $665.5M | 67.1% | $-22.8M | $47.3M | $— | — |
| FY null | $2.31B | 64.8% | $-309.9M | $-208.2M | $— | — |
| Q3 null | $592.2M | 64.9% | $-97.6M | $-87.5M | $— | — |
| Q2 null | $546.6M | 63.5% | $-110.4M | $-100.9M | $— | — |
| Q1 null | $501.8M | 63.2% | $-79.2M | $-66.9M | $— | — |
| Q4 null | $476.1M | 62.9% | $-64.7M | $-53.8M | $— | — |
| FY null | $1.70B | 60.3% | $-222.3M | $-190.4M | $— | — |
| Q3 null | $439.8M | 61.8% | $-39.3M | $-31.6M | $— | — |
| Q2 null | $413.4M | 58.8% | $-43.9M | $-37.5M | $— | — |
| Q1 null | $367.7M | 56.7% | $-74.3M | $-67.6M | $— | — |
| Q4 2023 | $311.1M | 51.4% | $-84.5M | $-78.0M | $-0.65 | — |